Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation (COAPT)
Status: Not Recruiting
The COAPT Trial is studying the MitraClip device in heart failure patients with functional mitral regurgitation to whom the local heart team will not offer mitral valve surgery as a treatment option. The trial compares the MitraClip device with no device in patients currently receiving optimal medical therapy.
Chad Rammohan, MD
Evalve, Inc, a subsidiary of Abbott Vascular
Janet Lamm, Clinical Research Coordinator
Taft Center for Clinical Research
For more information about this clinical trial, including trial status, eligibility and full trial listing, visit www.clinicaltrials.gov.